Cutler Group LP Natera, Inc. Put Options Transaction History

Cutler Group LP

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 Apr 19, 2024	BUY	$59.21 - $92.9 $65,131 - $102,190	1,100 New	1,100 $2,000
Q1 2023 May 01, 2023	SELL	$36.57 - $58.29 $10,971 - $17,487	-300 Reduced 60.0%	200 $0
Q4 2022 Feb 07, 2023	SELL	$34.17 - $47.91 $13,668 - $19,164	-400 Reduced 44.44%	500 $1,000
Q3 2022 Oct 25, 2022	SELL	$36.93 - $56.68 $332,370 - $510,120	-9,000 Reduced 90.91%	900 $0
Q2 2022 Aug 04, 2022	SELL	$28.13 - $44.54 $92,829 - $146,982	-3,300 Reduced 25.0%	9,900 $65,000
Q1 2022 Apr 14, 2022	BUY	$30.32 - $91.33 $400,224 - $1.21 Million	13,200 New	13,200 $88,000
Q4 2020 Jan 21, 2021	SELL	$66.66 - $111.74 $6,666 - $11,174	-100 Closed	0 $0
Q1 2019 May 10, 2019	SELL	$11.34 - $20.62 $20,412 - $37,116	-1,800 Reduced 94.74%	100 $0
Q3 2018 Nov 07, 2018	BUY	$18.82 - $28.96 $35,758 - $55,024	1,900 New	1,900 $4,000

527

118M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $15.7B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.